documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
78 rows where docket_id = "FDA-2016-N-0124" and posted_year = 2019 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 64
- Other 13
- Rule 1
posted_year 1
- 2019 · 78 ✖
agency_id 1
- FDA 78
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-0124-0353 | FDA | None FDA-2016-N-0124 | FINAL Third Extension Deferral Letter from FDA CDER to American Cleaning Institute | Other | Letter(s) | 2019-10-17T04:00:00Z | 2019 | 10 | 2019-10-17T04:00:00Z | 2019-10-17T15:39:32Z | 0 | 0 | 09000064840b4539 | ||
| FDA-2016-N-0124-0352 | FDA | None FDA-2016-N-0124 | Lonza FINAL July 3_2019 Prelim Meeting Preliminary Comment for July 2019 MTG (002) | Other | Minutes | 2019-09-19T04:00:00Z | 2019 | 9 | 2019-09-19T04:00:00Z | 2019-09-19T18:24:21Z | 0 | 0 | 0900006483f9ee0c | ||
| FDA-2016-N-0124-0351 | FDA | None FDA-2016-N-0124 | Letter from FDA CDER to American Cleaning Institute | Other | Letter(s) | 2019-08-09T04:00:00Z | 2019 | 8 | 2019-08-09T04:00:00Z | 2019-08-09T12:57:05Z | 0 | 0 | 0900006483e1e09f | ||
| FDA-2016-N-0124-0350 | FDA | None FDA-2016-N-0124 | Letter from FDA CDER to American Cleaning Institute | Other | Letter(s) | 2019-07-15T04:00:00Z | 2019 | 7 | 2019-07-15T04:00:00Z | 2019-07-15T18:46:13Z | 0 | 0 | 0900006483d91e24 | ||
| FDA-2016-N-0124-0349 | FDA | None FDA-2016-N-0124 | LONZA Meeting Request for July 9 Cancelled | Other | Letter(s) | 2019-07-09T04:00:00Z | 2019 | 7 | 2019-07-09T04:00:00Z | 2019-07-09T15:55:34Z | 0 | 0 | 0900006483d6f60a | ||
| FDA-2016-N-0124-0348 | FDA | None FDA-2016-N-0124 | Letter from FDA CDER to Lewis & Harrison | Other | Letter(s) | 2019-06-12T04:00:00Z | 2019 | 6 | 2019-06-12T04:00:00Z | 2019-09-19T16:52:24Z | 0 | 0 | 0900006483d09577 | ||
| FDA-2016-N-0124-0307 | FDA | None FDA-2016-N-0124 | Reference 20 - Kolawole, D. O., Resistance Mechanisms of Mucoid-Grown Staphylococcus aureus to the Antibacterial Action of Some Disinfectants re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:42Z | 0 | 0 | 0900006483b6a60c | |||
| FDA-2016-N-0124-0318 | FDA | None FDA-2016-N-0124 | Reference 40 - Lanker Klossner, B., et al., Nondevelopment of Resistance by Bacteria During Hospital Use of Povidone-Iodine re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:52Z | 0 | 0 | 0900006483b6a95d | |||
| FDA-2016-N-0124-0294 | FDA | None FDA-2016-N-0124 | Reference 2 – 6 – Volume_V_5_of_9_Published_Cited_References_Part_2_of_2_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:32Z | 0 | 0 | 0900006483b6a5f0 | |||
| FDA-2016-N-0124-0325 | FDA | None FDA-2016-N-0124 | Reference 33 - Weber, D. J. and W. A. Rutala, Use of Germicides in the Home and the Healthcare re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:59Z | 0 | 0 | 0900006483b6a62c | |||
| FDA-2016-N-0124-0333 | FDA | None FDA-2016-N-0124 | Reference 49 - Copitch, J. L., et al., Prevalence of Decreased Susceptibility to Triclosan in Salmonella re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:07Z | 0 | 0 | 0900006483b6a63f | |||
| FDA-2016-N-0124-0344 | FDA | None FDA-2016-N-0124 | Reference 35 - Akinkunmi, E. O. and A. Lamikanra, Susceptibility of Community Associated Methicillin Resistant re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:48Z | 0 | 0 | 0900006483b6a62e | |||
| FDA-2016-N-0124-0297 | FDA | None FDA-2016-N-0124 | Reference 2 – 3 – Volume_IV_3_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:34Z | 0 | 0 | 0900006483b6a4d3 | |||
| FDA-2016-N-0124-0343 | FDA | None FDA-2016-N-0124 | Reference 36 - Kawamura-Sato, K., et al., Reduction of Disinfectant Bactericidal Activities in Clinically Isolated Acinetobacter species in the re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:48Z | 0 | 0 | 0900006483b6a959 | |||
| FDA-2016-N-0124-0341 | FDA | None FDA-2016-N-0124 | Reference 41 - Oggioni, M. R., et al., Significant Differences Characterize the Correlation Coefficients Between Biocide and Antibiotic re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:46Z | 0 | 0 | 0900006483b6a960 | |||
| FDA-2016-N-0124-0312 | FDA | None FDA-2016-N-0124 | Reference 15 - Nagai, I. and H. Ogase, Absence of Role for Plasmids in Resistance to Multiple Disinfectants in Three re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:46Z | 0 | 0 | 0900006483b6a93b | |||
| FDA-2016-N-0124-0320 | FDA | None FDA-2016-N-0124 | Reference 38 - Khor, S. Y. and M. Jegathesan, In-Use testing of Disinfectants in Malaysian Government Hospitals re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:54Z | 0 | 0 | 0900006483b6a95b | |||
| FDA-2016-N-0124-0302 | FDA | None FDA-2016-N-0124 | Reference.List.Consumer.Rub.Final.Rule.2019 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:38Z | 0 | 0 | 0900006483b6a46b | |||
| FDA-2016-N-0124-0300 | FDA | None FDA-2016-N-0124 | Reference 2 - Comment submitted in Docket No. FDA-1975-N-0012-0081. Volume_I_1_of_9_Soap_ and_Detergent_ re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:37Z | 0 | 0 | 0900006483b6a4cf | |||
| FDA-2016-N-0124-0332 | FDA | None FDA-2016-N-0124 | Reference 50 - FDA Deferral Letter for Benzalkonium Chloride in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:06Z | 0 | 0 | 0900006483b6a640 | |||
| FDA-2016-N-0124-0310 | FDA | None FDA-2016-N-0124 | Reference 17 - Sakagami, Y. and K. Kajimura, Bactericidal Activities of Disinfectants against Vancomycin re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:45Z | 0 | 0 | 0900006483b6a93d | |||
| FDA-2016-N-0124-0345 | FDA | None FDA-2016-N-0124 | Reference 26 - Lacey, R. W., et al., Antiseptic Resistance in Methicillin-Resistant Staphylococcus aureus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:49Z | 0 | 0 | 0900006483b6a625 | |||
| FDA-2016-N-0124-0347 | FDA | None FDA-2016-N-0124 | Reference 7 – 1 FDA Deferral Letter for Isopropyl Alcohol in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:51Z | 0 | 0 | 0900006483b6a929 | |||
| FDA-2016-N-0124-0309 | FDA | None FDA-2016-N-0124 | Reference 18 - Haley, C. E., et al., Bactericidal Activity of Antiseptics Against Methicillin-Resistant Staphylococcus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:44Z | 0 | 0 | 0900006483b6a60a | |||
| FDA-2016-N-0124-0346 | FDA | None FDA-2016-N-0124 | Reference 25 - Kunisada, T., et al., Investigation on the Efficacy of Povidone-Iodine Against Antiseptic re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:50Z | 0 | 0 | 0900006483b6a613 | |||
| FDA-2016-N-0124-0287 | FDA | None FDA-2016-N-0124 | Reference 4 - Transcript of the October 20, 2005, Meeting of the Nonprescription Drugs Advisory Committee re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:28Z | 0 | 0 | 0900006483b6a925 | |||
| FDA-2016-N-0124-0321 | FDA | None FDA-2016-N-0124 | Reference 9 – Kramer, A., et. al., Quantity of Ethanol Absorption After Excessive Hand Disinfection Using Three Commercially re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:55Z | 0 | 0 | 0900006483b6a92c | |||
| FDA-2016-N-0124-0313 | FDA | None FDA-2016-N-0124 | Reference 14 - Czerwinski, S. E., et al., Novel Water-Based Antiseptic Lotion Demonstrates Rapid, Broad- Spectrum Kill Compared re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:47Z | 0 | 0 | 0900006483b6a93a | |||
| FDA-2016-N-0124-0292 | FDA | None FDA-2016-N-0124 | Reference 2 – 8 – Volume_VII_7_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:31Z | 0 | 0 | 0900006483b6a5f5 | |||
| FDA-2016-N-0124-0289 | FDA | None FDA-2016-N-0124 | Reference 2 – 11 – Volume_IX_9_of_9_Publsihed_Cited_ References_Part_2_of_2_re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:29Z | 0 | 0 | 0900006483b6a5f8 | |||
| FDA-2016-N-0124-0286 | FDA | None FDA-2016-N-0124 | Reference 5 - Summary Minutes of the November 14, 2008, Feedback Meeting with Personal re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:27Z | 0 | 0 | 0900006483b6a926 | |||
| FDA-2016-N-0124-0319 | FDA | None FDA-2016-N-0124 | Reference 39 - Rikimaru, T., et al., Bactericidal Activities of Commonly Used Antiseptics Against Multidrug-Resistant Mycobacterium re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:53Z | 0 | 0 | 0900006483b6a95c | |||
| FDA-2016-N-0124-0327 | FDA | None FDA-2016-N-0124 | Reference 31 - Noguchi, N., et al., Susceptibilities to Antiseptic Agents and Distribution of Antiseptic- Resistance Genes qacAB and smr re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:01Z | 0 | 0 | 0900006483b6a62a | |||
| FDA-2016-N-0124-0324 | FDA | None FDA-2016-N-0124 | Reference 34 - Rajamohan, G., et al., Biocide-Tolerant Multidrug-Resistant Acinetobacter baumannii Clinical Strains Are Associated with re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:58Z | 0 | 0 | 0900006483b6a62d | |||
| FDA-2016-N-0124-0329 | FDA | None FDA-2016-N-0124 | Reference 29 - Babaei, M et al Extremely re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:03Z | 0 | 0 | 0900006483b6a628 | |||
| FDA-2016-N-0124-0311 | FDA | None FDA-2016-N-0124 | Reference 16 - Geraldo, I. M., et al., Rapid Antibacterial Activity of 2 Novel Hand Soaps re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:46Z | 0 | 0 | 0900006483b6a93c | |||
| FDA-2016-N-0124-0315 | FDA | None FDA-2016-N-0124 | Reference 12 - Food and Drug Administration, Guidance for Industry. M3(R2) Nonclinical Safety Studies for the Conduct of re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:49Z | 0 | 0 | 0900006483b6a938 | |||
| FDA-2016-N-0124-0293 | FDA | None FDA-2016-N-0124 | Reference 2 – 7 – Volume_VI_6_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:32Z | 0 | 0 | 0900006483b6a5f4 | |||
| FDA-2016-N-0124-0290 | FDA | None FDA-2016-N-0124 | Reference 2 – 10 – Volume_IX_9_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:29Z | 0 | 0 | 0900006483b6a5f7 | |||
| FDA-2016-N-0124-0298 | FDA | None FDA-2016-N-0124 | Reference 2 – 2 – Volume_III_3_of_9_Reference_List_re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:35Z | 0 | 0 | 0900006483b6a4d1 | |||
| FDA-2016-N-0124-0291 | FDA | None FDA-2016-N-0124 | Reference 2 – 9 – Volume_VIII_8_of_9_References_Continuation_ re_ Comment_Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:30Z | 0 | 0 | 0900006483b6a5f6 | |||
| FDA-2016-N-0124-0288 | FDA | None FDA-2016-N-0124 | Reference 3 - Transcript of the March 23, 2005, Nonprescription Drugs Advisory Committee re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:28Z | 0 | 0 | 0900006483b6a5f9 | |||
| FDA-2016-N-0124-0305 | FDA | None FDA-2016-N-0124 | Reference 22 - Sivaji, Y., et al., Disinfectant Induced Changes in the Antibiotic Sensitivity and Phage Typing Pattern in Staphylococcus aureus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:41Z | 0 | 0 | 0900006483b6a610 | |||
| FDA-2016-N-0124-0284 | FDA | None FDA-2016-N-0124 | Reference 7 - FDA Deferral Letter for Ethyl Alcohol in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:25Z | 0 | 0 | 0900006483b6a928 | |||
| FDA-2016-N-0124-0295 | FDA | None FDA-2016-N-0124 | Reference 2 – 5 – Volume_V_5_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:33Z | 0 | 0 | 0900006483b6a4d5 | |||
| FDA-2016-N-0124-0338 | FDA | None FDA-2016-N-0124 | Reference 44 - Buffet-Bataillon, S., et al., Effect of Higher Minimum Inhibitory Concentrations of Quaternary Ammonium Compounds re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:11Z | 0 | 0 | 0900006483b6a63a | |||
| FDA-2016-N-0124-0322 | FDA | None FDA-2016-N-0124 | Reference 8 – Brown, T. L., et al., Can Alcohol-Based Hand-Rub Solutions Cause You to Lose Your Driver’s License Comparative re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:56Z | 0 | 0 | 0900006483b6a92b | |||
| FDA-2016-N-0124-0304 | FDA | None FDA-2016-N-0124 | Reference 23 - Young, R., et al., Comparative In Vitro Efficacy of Antimicrobial Shampoos A Pilot Study re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:40Z | 0 | 0 | 0900006483b6a611 | |||
| FDA-2016-N-0124-0323 | FDA | None FDA-2016-N-0124 | Reference 7 – 2 FDA Deferral Letter for Benzalkonium Chloride in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:57Z | 0 | 0 | 0900006483b6a92a | |||
| FDA-2016-N-0124-0342 | FDA | None FDA-2016-N-0124 | Reference 37 - Kawamura-Sato, K., et al., Correlation Between Reduced Susceptibility to Disinfectants and Multidrug Resistance Among Clinical re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:47Z | 0 | 0 | 0900006483b6a95a | |||
| FDA-2016-N-0124-0299 | FDA | None FDA-2016-N-0124 | Reference 2 – 1 – Volume_II_2_of_9_Feedback_Meeting_and_Working_Texts_From_the_Feedback_ Meeting_March_29_1995_Attachment_1_through_6 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:36Z | 0 | 0 | 0900006483b6a4d0 | |||
| FDA-2016-N-0124-0301 | FDA | None FDA-2016-N-0124 | Reference 1 - Transcript of the January 22, 1997, Joint Meeting of the Nonprescription Drugs and Anti re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:37Z | 0 | 0 | 0900006483b6a46c | |||
| FDA-2016-N-0124-0308 | FDA | None FDA-2016-N-0124 | Reference 19 - Johnson, S. A., et al., Comparative Susceptibility of Resident and Transient Hand Bacteria to Para-chloro- re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:43Z | 0 | 0 | 0900006483b6a60b | |||
| FDA-2016-N-0124-0334 | FDA | None FDA-2016-N-0124 | Reference 48 - Morrissey, I., et al., Evaluation of Epidemiological Cut-Off Values Indicates That Biocide Resistant Subpopulations Are Uncommon re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:08Z | 0 | 0 | 0900006483b6a63e | |||
| FDA-2016-N-0124-0339 | FDA | None FDA-2016-N-0124 | Reference 43 - Stickler, D. J., et al., Antiseptic and Antibiotic Resistance in Gram-Negative Bacteria Causing Urinary re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:44Z | 0 | 0 | 0900006483b6a962 | |||
| FDA-2016-N-0124-0337 | FDA | None FDA-2016-N-0124 | Reference 45 - Shi, G. S., et al., Prevalence of Antiseptic-Resistance Genes in Staphylococci Isolated from re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:10Z | 0 | 0 | 0900006483b6a63b | |||
| FDA-2016-N-0124-0340 | FDA | None FDA-2016-N-0124 | Reference 42 - Coelho, J. R., et al., The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T19:00:45Z | 0 | 0 | 0900006483b6a961 | |||
| FDA-2016-N-0124-0335 | FDA | None FDA-2016-N-0124 | Reference 47 - Prince, H. N., et al., Drug Resistance Studies with Topical Antiseptics re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:09Z | 0 | 0 | 0900006483b6a63d | |||
| FDA-2016-N-0124-0330 | FDA | None FDA-2016-N-0124 | Reference 28 - Furi, L., et al., Evaluation of Reduced Susceptibility to Quaternary Ammonium Compound re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:04Z | 0 | 0 | 0900006483b6a627 | |||
| FDA-2016-N-0124-0317 | FDA | None FDA-2016-N-0124 | Reference 10 – Miller, M. A., et. al., Does the Clinical Use of Ethanol-Based Hand Sanitizer Elevate Blood Alcohol Levels re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:51Z | 0 | 0 | 0900006483b6a92d | |||
| FDA-2016-N-0124-0303 | FDA | None FDA-2016-N-0124 | Reference 24 - Block, C., et al., Evaluation of Chlorhexidine and Povidone Iodine Activity Against Methicillin-Resistant Staphylococcus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:39Z | 0 | 0 | 0900006483b6a612 | |||
| FDA-2016-N-0124-0326 | FDA | None FDA-2016-N-0124 | Reference 32 - Shamsudin, M. N., et al., High Prevalence of qacAB Carriage Among Clinical Isolates of Meticillin-Resistant Staphylococcus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:00Z | 0 | 0 | 0900006483b6a62b | |||
| FDA-2016-N-0124-0328 | FDA | None FDA-2016-N-0124 | Reference 30 - Ghasemzadeh-Moghaddam, H., et al., Methicillin-Susceptible and-Resistant Staphylococcus aureus With High-Level Antiseptic re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:02Z | 0 | 0 | 0900006483b6a629 | |||
| FDA-2016-N-0124-0336 | FDA | None FDA-2016-N-0124 | Reference 46 - Lambert, R. J., Comparative Analysis of Antibiotic and Antimicrobial Biocide Susceptibility Data re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:10Z | 0 | 0 | 0900006483b6a63c | |||
| FDA-2016-N-0124-0331 | FDA | None FDA-2016-N-0124 | Reference 27 - Liu, Q., et al., Sensitivities to Biocides and Distribution of Biocide Resistance Genes in Quaternary Ammonium Compound Tolerant re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:59:05Z | 0 | 0 | 0900006483b6a626 | |||
| FDA-2016-N-0124-0306 | FDA | None FDA-2016-N-0124 | Reference 21 - Sivaji, Y. and A. Mandal, Antibiotic Resistance and Serotypic Variations in Escherichia coli Induced by re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:42Z | 0 | 0 | 0900006483b6a60f | |||
| FDA-2016-N-0124-0285 | FDA | None FDA-2016-N-0124 | Reference 6 - Transcript of the September 3, 2014, Meeting of the Nonprescription Drugs Advisory Committee 2014 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:26Z | 0 | 0 | 0900006483b6a927 | |||
| FDA-2016-N-0124-0316 | FDA | None FDA-2016-N-0124 | Reference 11 – Food and Drug Administration, Guidance for Industry. Maximal Usage Trials for Topical Active Ingredients Being Considered re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:50Z | 0 | 0 | 0900006483b6a937 | |||
| FDA-2016-N-0124-0296 | FDA | None FDA-2016-N-0124 | Reference 2 – 4 – Volume_IV_4_of_9_Published_Cited_References_Part_2_of_2_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:34Z | 0 | 0 | 0900006483b6a4d4 | |||
| FDA-2016-N-0124-0314 | FDA | None FDA-2016-N-0124 | Reference 13 - Bearden, D. T., et al., Comparative In Vitro Activities of Topical Wound Care Products Against re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2019-06-05T04:00:00Z | 2019 | 6 | 2019-06-05T18:58:48Z | 0 | 0 | 0900006483b6a939 | |||
| FDA-2016-N-0124-0283 | FDA | None FDA-2016-N-0124 | Briefing Document from Lewis and Harrison on behalf of Lonza Inc. and Henkel Consumer Goods, Inc. | Other | Brief | 2019-05-31T04:00:00Z | 2019 | 5 | 2019-05-31T04:00:00Z | 2019-05-31T20:36:58Z | 0 | 0 | 0900006483cddf54 | ||
| FDA-2016-N-0124-0281 | FDA | None FDA-2016-N-0124 | Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Rule | Final Rule | 2019-04-12T04:00:00Z | 2019 | 4 | 2019-04-12T04:00:00Z | 2019-04-12T13:14:40Z | 2019-06791 | 0 | 0 | 0900006483b89f68 | |
| FDA-2016-N-0124-0279 | FDA | None FDA-2016-N-0124 | Letter from FDA CDER to Bayer Corporation | Other | Letter(s) | 2019-04-11T04:00:00Z | 2019 | 4 | 2019-04-11T04:00:00Z | 2019-04-11T16:48:48Z | 0 | 0 | 0900006483b85971 | ||
| FDA-2016-N-0124-0278 | FDA | None FDA-2016-N-0124 | Letter from FDA CDER to Ciba Specialty Chemicals Corporation | Other | Letter(s) | 2019-04-11T04:00:00Z | 2019 | 4 | 2019-04-11T04:00:00Z | 2019-04-11T16:46:32Z | 0 | 0 | 0900006483b856f5 | ||
| FDA-2016-N-0124-0280 | FDA | None FDA-2016-N-0124 | Letter from FDA CDER to Ciba Specialty Chemicals Corporation | Other | Letter(s) | 2019-04-11T04:00:00Z | 2019 | 4 | 2019-04-11T04:00:00Z | 2019-04-11T16:51:14Z | 0 | 0 | 0900006483b85974 | ||
| FDA-2016-N-0124-0277 | FDA | None FDA-2016-N-0124 | Request for a Type C Meeting from Lewis and Harrison on behalf of Lorenz Inc., and Henkel Corporation | Other | Request | 2019-04-09T04:00:00Z | 2019 | 4 | 2019-04-09T04:00:00Z | 2019-04-09T19:01:15Z | 0 | 0 | 0900006483b7a9d3 | ||
| FDA-2016-N-0124-0276 | FDA | None FDA-2016-N-0124 | Request for a Deferral from Keller and Heckman LLP on behalf of CleanWell LLC | Other | Request | 2019-03-26T04:00:00Z | 2019 | 3 | 2019-03-26T04:00:00Z | 2019-03-26T21:16:11Z | 0 | 0 | 0900006483b319e2 | ||
| FDA-2016-N-0124-0275 | FDA | None FDA-2016-N-0124 | Report from American Cleaning Institute (ACI) | Other | Report | 2019-03-13T04:00:00Z | 2019 | 3 | 2019-03-13T04:00:00Z | 2019-03-13T20:22:54Z | 0 | 0 | 0900006483ad8541 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;